Canadian Headache Society guideline for migraine prophylaxis.
Level 5 - mechanism / opinion, no new human data
Evidence-based clinical practice guideline combining systematic review of randomized trials with expert consensus.
What was done
The Canadian Headache Society developed clinical practice guidelines for episodic migraine prophylaxis (headache on ≤14 days per month). The panel conducted a comprehensive search for randomized, double-blind, controlled trials and Cochrane reviews of drug treatments. Studies were evaluated using US Preventive Services Task Force criteria, and recommendations were graded using the GRADE methodology. General literature review and expert consensus were applied for clinical questions lacking randomized trial evidence.
What was found
Eleven prophylactic agents received a strong recommendation for use: topiramate, propranolol, nadolol, metoprolol, amitriptyline, gabapentin, candesartan, butterbur, riboflavin, coenzyme Q10, and magnesium citrate. Six agents received a weak recommendation: divalproex sodium, flunarizine, pizotifen, venlafaxine, verapamil, and lisinopril. Quality of evidence for specific medications varied from high to low. No quantitative effect sizes, responder rates, or study counts were reported in the abstract. Tailored strategies were outlined for treatment-naive patients, low-side-effect options, comorbid hypertension or depression/anxiety, elevated body mass index, previous trial failures, refractory migraine, and pregnancy or lactation.
Why it matters
This guideline provides clinicians with an evidence-graded framework to match pharmacologic and nutraceutical prophylactic options to individual clinical profiles and comorbidities in episodic migraine.
Limits
The abstract does not provide numerical effect sizes, confidence intervals, or the total number of included trials and patients. Evidence quality was heterogeneous across recommended agents, and clinical guidance for specific scenarios (e.g., pregnancy, lactation, refractory cases) relied partly on expert consensus due to a lack of randomized controlled trials.
Cited by
- supports Butterbur herb is supported by solid research as an effective remedy for migraine headaches.